#076: Alemtuzumab (Lemtrada, Campath) for highly active relapsing MS
Alemtuzumab (Lemtrada, Campath) is a DMT to treat highly active MS and has long-lasting effects and potential severe side effects. You can read the full article on my blog: https://ms-perspektive.com/...
28 Elo 202427min
#075: Decoding the EDSS Score. How It's Measured and What It Means
The EDSS score helps neurologists to measure the progression of MS as it measures limitations in functional systems. You can find the full article at: https://ms-perspektive.com/75-edss Th...
21 Elo 20247min
#074: S1P Modulators - Fingolimod (Gilenya), Ozanimod (Zeposia), Ponesimod (Ponvory), Siponimod (Mayzent) for active RRMS & SPMS
Learn more about the S1P Modulators, known by the brand names Gilenya, Zeposia, Ponvory, Mayzent and their usage against active RRMS & SPMS. You can find the complete text to read on my blog: https://...
14 Elo 202431min
#073: "Haciendo Lo Invisible, Visible". Crys's Journey of Invisible Battles and Visible Triumphs as Latina with MS in the US
Crys was diagnosed with MS at the age of 11. She talks about her experiences as a first-generation Latina and her mission on social media. You can find all questions and answers on my blog: https://ms...
7 Elo 202452min
#072: Natalizumab (Tysabri, Tyruko) for active relapsing remitting MS
Natalizumab (Tysabri, Tyruko) is approved as disease-modifying therapy (DMT) for active RRMS with a rapidly evolving severe MS. You can read the complete article on my blog: https://ms-perspektive.com...
31 Heinä 202422min
#071: Insights into MS treatment in Colombia with neurologist Dr. Adriana Casallas Vanegas
Dr. Adriana Casallas V. provides insights into the treatment and care of MS patients in Colombia including improvements and challenges. You can find all questions and answers to read through on my blo...
24 Heinä 202441min
#070: Teriflunomide (Aubagio) for relapsing remitting MS
Teriflunomide (Aubagio) is approved as disease-modifying therapy for mild to moderate RRMS from 10 years of age. You can find the full article to read on my blog: https://ms-perspektive.com/70-teriflu...
17 Heinä 202419min
#069: Beyond Boundaries. Advocacy, Research, and Recognition in MS with Rachel Horne
MS patient and advocate Rachel Horne sponsors a prize for women in MS research and campaigns for more diversity in clinical trials. You can read all questions and answers on my blog: https://ms-perspe...
10 Heinä 20241h
